Squamous cell carcinoma of the esophagus in association with long-term immunosuppressive therapy.
An increased risk of skin and lymphoreticular malignancies is well documented in renal transplant patients receiving long-term immunosuppressive therapy, but squamous cell carcinoma of the esophagus is rare. We have reported the first case in the English literature in which there is a strong association between long-term immunosuppressive therapy and squamous cell carcinoma of the esophagus. It occurred in a 28-year-old white man ten years after cadaveric kidney transplantation.
Scobey
M W
MW
Department of Medicine, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27103.
Kerr
B J
BJ
Geisinger
K R
KR
Hamilton
R W
RW
Richter
J E
JE
D000328:Adult; D002294:Carcinoma, Squamous Cell / Q000209:etiology*; D004938:Esophageal Neoplasms / Q000209:etiology*; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation; D008297:Male; D012307:Risk Factors; D013997:Time Factors
D007166:Immunosuppressive Agents